| Analysis | Metabolite Name | Measured Value | Units | Treatment |
|---|---|---|---|---|
| Reversed phase NEGATIVE ION MODE | citrate | 390053.2 | Peak area (top) | ML210 |
| Reversed phase NEGATIVE ION MODE | citrate | 436521.1 | Peak area (top) | ML210 |
| Reversed phase NEGATIVE ION MODE | citrate | 439669.1 | Peak area (top) | ML210 |
| Reversed phase NEGATIVE ION MODE | citrate | 487248.6 | Peak area (top) | DMSO |
| Reversed phase NEGATIVE ION MODE | citrate | 535308.6 | Peak area (top) | RSL3 |
| Reversed phase NEGATIVE ION MODE | citrate | 548041.2 | Peak area (top) | DMSO |
| Reversed phase NEGATIVE ION MODE | citrate | 549674.7 | Peak area (top) | ML162 |
| Reversed phase NEGATIVE ION MODE | citrate | 596350.1 | Peak area (top) | ML162 |
| Reversed phase NEGATIVE ION MODE | citrate | 605450.2 | Peak area (top) | DMSO |
| Reversed phase NEGATIVE ION MODE | citrate | 667318.2 | Peak area (top) | ML162 |
| Reversed phase NEGATIVE ION MODE | citrate | 673068.9 | Peak area (top) | RSL3 |
| Reversed phase NEGATIVE ION MODE | citrate | 730447.2 | Peak area (top) | RSL3 |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|